Epidemiology and Molecular Basis of Resistance to Fluconazole Among Clinical Candida parapsilosis Isolates in Kuwait
Affiliations
Affiliations
- Department of Microbiology, Faculty of Medicine, Kuwait University , Safat, Kuwait .
Abstract
Fluconazole resistance among clinical Candida parapsilosis isolates is an emerging problem in many countries, including Kuwait. Resistance to fluconazole is mediated by amino acid substitutions in ERG11 and/or by overexpression of efflux pumps MDR1 and CDR1. Clinical C. parapsilosis sensu stricto isolates (n = 442) were tested for susceptibility to fluconazole by Etest, Vitek II, and broth microdilution methods. ERG11 was analyzed from fluconazole-resistant, fluconazole-susceptible dose-dependent, and selected fluconazole-susceptible isolates. Of 442 C. parapsilosis isolates, 425, 2, and 15 were identified as susceptible, susceptible dose-dependent, and resistant to fluconazole, respectively. PCR sequencing of ERG11 identified Y132F mutation in 5 of 11 fluconazole-resistant isolates available for analysis. This mutation was absent in 46 fluconazole-susceptible and 2 fluconazole-susceptible dose-dependent isolates. A multiplex allele-specific PCR was developed for detection of Y132F mutation in ERG11, and results correlated perfectly with PCR sequencing data for ERG11 codon 132 for all isolates analyzed. Detection of resistance in 15 and reduced susceptibility in 2 among 442 C. parapsilosis isolates highlights emerging resistance to fluconazole in Kuwait. The Y132F mutation in ERG11 was found in 5 of 11 (45%) fluconazole-resistant isolates only. Detection of fluconazole resistance in C. parapsilosis will help in proper management of patients infected with this species.
Keywords: Candida parapsilosis; ERG11 mutations; fluconazole resistance; rapid detection.
Similar articles
Castanheira M, Deshpande LM, Messer SA, Rhomberg PR, Pfaller MA.Int J Antimicrob Agents. 2020 Jan;55(1):105799. doi: 10.1016/j.ijantimicag.2019.09.003. Epub 2019 Sep 11.PMID: 31520783
Singh A, Singh PK, de Groot T, Kumar A, Mathur P, Tarai B, Sachdeva N, Upadhyaya G, Sarma S, Meis JF, Chowdhary A.J Antimicrob Chemother. 2019 May 1;74(5):1260-1268. doi: 10.1093/jac/dkz029.PMID: 30753525
Choi YJ, Kim YJ, Yong D, Byun JH, Kim TS, Chang YS, Choi MJ, Byeon SA, Won EJ, Kim SH, Shin MG, Shin JH.Emerg Infect Dis. 2018 Sep;24(9):1768-1770. doi: 10.3201/eid2409.180625.PMID: 30124412 Free PMC article.
Esfahani A, Omran AN, Salehi Z, Shams-Ghahfarokhi M, Ghane M, Eybpoosh S, Razzaghi-Abyaneh M.Microb Pathog. 2022 Sep;170:105696. doi: 10.1016/j.micpath.2022.105696. Epub 2022 Jul 31.PMID: 35921954 Review.
Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC.Dan Med J. 2013 Nov;60(11):B4698.PMID: 24192246 Review.
Cited by
Asadzadeh M, Alfouzan W, Parker JE, Meis JF, Kelly SL, Joseph L, Ahmad S.Microbiol Spectr. 2023 Aug 17;11(4):e0147423. doi: 10.1128/spectrum.01474-23. Epub 2023 Jun 26.PMID: 37358415 Free PMC article.
Ceballos-Garzon A, Peñuela A, Valderrama-Beltrán S, Vargas-Casanova Y, Ariza B, Parra-Giraldo CM.Front Cell Infect Microbiol. 2023 Mar 21;13:1136217. doi: 10.3389/fcimb.2023.1136217. eCollection 2023.PMID: 37026059 Free PMC article.
Urbanek AK, Łapińska Z, Derkacz D, Krasowska A.Pathogens. 2022 Nov 3;11(11):1289. doi: 10.3390/pathogens11111289.PMID: 36365040 Free PMC article.
Kim TY, Huh HJ, Lee GY, Choi MJ, Yu HJ, Cho SY, Chang YS, Kim YJ, Shin JH, Lee NY.Antimicrob Agents Chemother. 2022 Nov 15;66(11):e0088922. doi: 10.1128/aac.00889-22. Epub 2022 Oct 13.PMID: 36226945 Free PMC article.
Yamin D, Akanmu MH, Al Mutair A, Alhumaid S, Rabaan AA, Hajissa K.Trop Med Infect Dis. 2022 Aug 16;7(8):188. doi: 10.3390/tropicalmed7080188.PMID: 36006280 Free PMC article. Review.